Chronic relapsing inflammatory optic neuropathy

disease
On this page

Also known as chronic recurrent isolated optic neuritisCRION

Summary

Chronic relapsing inflammatory optic neuropathy (MONDO:0044687) is a disease. A subtype of autoimmune/inflammatory optic neuropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namechronic relapsing inflammatory optic neuropathy
Mondo IDMONDO:0044687
Orphanet499085
UMLSC5567234
MedGen1798657
GARD0022038
Is cancer (heuristic)no

Also known as: chronic recurrent isolated optic neuritis · CRION

Disease family

Classification path: disease › human disease › disease by body system or component › disorder of orbital regioneye disorder › autoimmune/inflammatory optic neuropathy › chronic relapsing inflammatory optic neuropathy

Related subtypes (4): neuromyelitis optica, isolated optic neuritis, recurrent idiopathic neuroretinitis, optic perineuritis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.